Tarsus Pharmaceuticals, Inc. TARS Deferred Tax Liabilities, Property, Plant and Equipment
Deferred Tax Liabilities, Property, Plant and Equipment at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s deferred tax liabilities, property, plant and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s deferred tax liabilities, property, plant and equipment?
- Tarsus Pharmaceuticals, Inc. (TARS) reported deferred tax liabilities, property, plant and equipment of $186K in Q4 2025.